Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

Home

Our Products

An opportunity to participate in a range of diverse portfolios, proactively managed by our sector experienced team. Tax advantages are potentially available via the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. Please view our specific product pages for more information. Financial Advice is recommended.

An opportunity for investors participate in a portfolio of growth-focused technology companies, whilst taking advantage of the potential tax benefits available under the Enterprise Investment Scheme.

An opportunity for investors to participate in a portfolio of growth-focused healthcare innovation companies, whilst taking advantage of the potential tax benefits available under the Enterprise Investment Scheme.

An asset-backed opportunity for investors to target long-term capital growth by investing in renewable energy generating trading assets.

An opportunity for investors to participate in a portfolio of seed-stage technology innovation companies, whilst taking advantage of the potential tax benefits available under the Seed Enterprise Investment Scheme.

The Private Investor Network of Deepbridge Capital, enabling experienced investors to define their own portfolio of innovative Life Sciences and Technology companies.

Deepbridge Protect is an IHT mitigation service that seeks to help businesses obtain full IHT relief, through their membership of a trading Partnership participating in a qualifying trade, so as to qualify for Business Relief.

Why you should invest with Deepbridge

Deepbridge Capital aims to redefine the growth capital market by providing you with access to opportunities which are sourced, reviewed and managed by our team of sector specialists.

Supporting energetic, passionate and knowledgeable management teams, Deepbridge seeks to identify highly innovative companies to grow into highly successful companies, with a view to providing optimal returns to our investors.

As an investment specialist in the technology, life sciences and renewable energy sectors, we work with investee companies throughout their funding journey with an eye on always producing a suitable exit for our investors.

Typically monthly deployments
Sector-experienced team
Thorough due-diligence process
Hands-on and active approach

 

Read More about Deepbridge

 

100% Tax Efficiency for Investors

No management charges are levied on the investor at the point of investment for advised subscriptions received by a financial adviser, resulting in up to 100% allocation of subscription. This ensures up to 100% tax efficiency for investors. Deepbridge Capital fees are paid by Investee Companies and are disclosed in the Information Memorandum.

Testimonials

"Our partnership with Deepbridge is based around shared goals and mutual trust. Deepbridge understands the commercialisation process of a medical technology (MedTech) company and this makes them a fantastic partner for Sky Medical Technology. They see the potential in our business, provide the necessary support to help us fulfil our potential and help us create the environment for sustained success in the MedTech market. Their genuine enthusiasm and passion for what we do inspires the decisions we make."

Bernard Ross (CEO) Sky Medical Technology

"Our partnership with Deepbridge has been invaluable in growing our business. Their active and hands-on approach was exactly what we were looking for when searching for a
funding partner, we wanted someone that not only understood our vision, but could also apply their experience to add real value to our organisation and that’s exactly what they have done. I look forward to working with them over the coming years, as we aim to provide investors with an optimum return on investment."

Kam Pooni (CEO) Glyconics

"Deepbridge Capital has been a critical partner in establishing Hurricane as the market leader in cross border eCommerce supply chain data provision. Deepbridge’s ability to generate the necessary financing to develop our innovative solutions, combined with the abundance of highly gifted personnel throughout their team to help guide our business, has been truly outstanding."

Martyn Noble (CHAIRMAN & CEO) Hurricane Modular Commerce

"Deepbridge has been a steadfast supporter of Chainvine. Having them as our principal investor has helped Chainvine open doors to clients and other funds that otherwise would have remained closed to a technology start-up."

Oliver Oram (CEO) Chainvine

"It was extremely important for Elasmogen that we worked with the right funding partners. Deepbridge's Life Sciences team understands our company and our sector, with their support therefore being invaluable and
much appreciated.
"

Caroline Barelle, Elasmogen Limited (CEO)

"We have been extremely pleased to work with the Deepbridge team as arbnco has grown, having consistently demonstrated their faith in our proposition and our objectives. Their commitment to working in partnership with us has been truly invaluable."

Maureen Eisbrenner, arbnco (CEO)

Latest News

FluoretiQ Secures Patent for Antibiotic Test
FluoretiQ Secures Patent for Antibiotic Test

6th August 2024

FluoretiQ, which is part of the Deepbridge Life Sciences EIS portfolio, is excited to share that their European patent for SCFI has been granted!…

Full article
Deepbridge Growth Investor Awards Finalists 2024
Deepbridge Finalist at Growth Investor Awards 2024

2nd August 2024

Deepbridge Capital is a finalist for an award at the upcoming Growth Investor 2024 Awards, taking place 21st November at the London Hilton, Park Lane…

Full article
Enso News
ENSO to Build $500M Tyre Factory

3rd July 2024

ENSO, which is part of the Deepbridge Technology Growth EIS portfolio, has recently signed a Letter of Interest (LOI) with the Export-Import Bank of…

Full article

Events

1. EIS Basis Modern World of EIS_01.jpeg
EIS: The Basics - The Modern World Of EIS (Episode 1)

10th September 2024

We are delighted to invite you to attend our series of 3 webinars, offering financial advisers the opportunity to learn more about EIS and consider…

Event Details
2. EIS Basics Trigger Points_01.jpeg
EIS: The Basics - Trigger Points (Episode 2)

17th September 2024

We are delighted to invite you to attend our series of 3 webinars, offering financial advisers the opportunity to learn more about EIS and consider…

Event Details
3. EIS Basics Due Diligence Research_01.jpeg
EIS: The Basics - Due Diligence & Research (Episode 3)

24th September 2024

We are delighted to invite you to attend our series of 3 webinars, offering financial advisers the opportunity to learn more about EIS and consider…

Event Details